Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850811 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
A Phase 1 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00850811 is a Phase 1 study that has completed, run by Peplin. The registered enrollment target is 30 participants.
The verdict
NCT00850811, a Phase 1 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure.
Interventions
- DRUG PEP005 (ingenol mebutate) Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00850811
The ClinicalTrials.gov registry entry for NCT00850811 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEP005 (ingenol mebutate) Gel is the first listed.
NCT00850811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00850811 about?
NCT00850811 is a clinical study titled "A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers". This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure.
What is the current status of trial NCT00850811?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00850811?
The interventions under investigation include: PEP005 (ingenol mebutate) Gel (DRUG).
Who is sponsoring clinical trial NCT00850811?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.